baber/WOPTO huggingface dataset:
Patent EP-1057803-B1 (EP)
Inventor: YOKOMORI YOROZU
IPC: C07C31/125
Filed: 2000-05-24
Granted: 2004-01-21
Abstract: Provided is a process for producing alcohols or aldehydes by reacting monoolefins with carbon monoxide and hydrogen with less formation of by-products. The process comprises the step of reacting a monoolefin with carbon monoxide and hydrogen in the presence of a cobalt carbonyl catalyst until the conversion of monoolefin reaches 50-90% (the first reaction step), the step of separating unreacted monoolefin from the reaction mixture obtained in the first reaction step (the step of separation of unreacted monoolefin) and the step of reacting the separated unreacted monoolefin with carbon monoxide and hydrogen in the presence of a cobalt carbonyl catalyst (the second reaction step), wherein at least one of the first reaction step and the second reaction step is carried out in the presence of water. <IMAGE>
Patent EP-1052825-B1 (EP)
Inventor: EKBERG JAN-ERIK
IPC: G06F21/31
Filed: 2000-05-03
Granted: 2004-02-18
Abstract: The invention is a method and system for obtaining connection to a packet data network (14). The invention includes inputting a user request to a first network (10) which requests that the user (12) be authorized for connection to the packet data network through a second network; transmitting from the first network to the second network the user request and an authorization of payment to the second network by the first network for the users use of the packet data network; transmitting from the second network to the first network authentication information granting the user authentication through the second network to the packet data network; and transmitting the authentication information from the first network to the user which informs the user that authentication to obtain connection to the packet data network has been granted.
Patent EP-1152753-B1 (EP)
Inventor: CLARKE JEREMY GUY
IPC: A61K31/57
Filed: 2000-02-16
Granted: 2004-05-12
Abstract: Cette invention concerne une composition pharmaceutique renfermant (A) du formoterol ou un sel de ce composé acceptable au plan pharmaceutique ou un solvat du formoterol ou dudit sel, et (B) du fluticasone propionate. Cette composition convient pour le traitement des maladies inflammatoires ou obstructives des voies respiratoires.
Patent EP-1173699-B1 (EP)
Inventor: WARD NIC
IPC: G01B5/004
Filed: 2000-02-02
Granted: 2005-04-13
Abstract: Device for subsea metrology of distance and relative orientation of a first termination (10) with a local reference system (xr, yr, zr) and which by means of a jumper spool piece (5) is going to be connected to a separate second termination (20) having a local reference system (xB, yB, zB), characterized by a base metrology unit (2) arranged for being carried by an ROV (4), and arranged for aligned arrangement with the second or the first termination's (20, 10) reference system, and comprising the following features: a wire (3) with an extractable first end (31) being arranged for being attached to a receptacle device (7, 7') arranged on the termination (10, 20) for receiving the wire's (3) first end (31) or a metrology unit and with a wire tensioner device (32) arranged for tensioning the wire (3) between the base metrology unit (2) and the receptacle device (7, 7'); a wire length sensor (34) arranged for measuring the length (DrB) of the extended taut wire (3); a relative azimuth sensing device (92) arranged to measure [and store] the relative azimuth (thetaB, thetar) value of the taut wire (3) with respect to the base metrology unit's (2) mainly horizontal axes (xB, yB); and a submerged-depth sensor (52) arranged for measuring the submerged depth (dB) of the base metrology unit (2).
Patent EP-1171715-B1 (EP)
Inventor: SCHOEN OTMAR
IPC: F15B1/08
Filed: 2000-03-25
Granted: 2007-10-31
Abstract: A method monitors the gas prefill pressure in hydraulic accumulators. After the pressure supply to the oil side of the accumulator has been interrupted and the contents of the tank have been emptied, the current gas temperature and the current gas pressure are determined, once the temperature has equalized. The data relating to the gas temperature and pressure is telemetrically transmitted to an evaluation unit, which is spatially located at a distance, to calculate an actual value of the gas prefill pressure which corresponds to a reference temperature.
Patent EP-1166007-B1 (EP)
Inventor: JAERVENKYLAE JYRI
IPC: B29K23/00
Filed: 2000-03-31
Granted: 2004-02-18
Abstract: A plastic pipe provided with a socket and a method of providing a plastic pipe with a socket, whereby the socket comprises at least two layers. The orientation of at least one socket layer is different from the orientation of another layer and the orientation of at least one layer is different from the orientation of a body portion of the plastic pipe. The socket is made for instance from a plastic pipe comprising at least two layers. The orientation temperatures of at least two different layers are different. The plastic pipe is heated to a temperature at which the material of at least one layer is oriented during expansion and the material of at least one layer is substantially not oriented during expansion. The end of the plastic pipe is expanded at said temperature so as to provide it with a socket.
Patent EP-1194449-B1 (EP)
Inventor: TANG JORDAN J N
IPC: A61P25/28
Filed: 2000-06-27
Granted: 2010-09-22
Abstract: Methods for the production of purified, catalytically active, recombinant memapsin 2 have been developed. The substrate and subsite specificity of the catalytically active enzyme have been determined. The substrate and subsite specificity information was used to design substrate analogs of the natural memapsin 2 substrate that can inhibit the function of memapsin 2. The substrate analogs are based on peptide sequences, shown to be related to the natural peptide substrates for memapsin 2. The substrate analogs contain at least one analog of an amide bond which is not capable of being cleaved by memapsin 2. Processes for the synthesis of two substrate analogues including isosteres at the sites of the critical amino acid residues were developed and the substrate analogues, OMR99-1 and OM99-2, were synthesized. OM99-2 is based on an octapeptide Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe (SEQ ID NO:28) with the Leu-Ala peptide bond substituted by a transition-state isostere hydroxyethylene group (FIG. 1). The inhibition constant of OM99-2 is 1.6×10−9 M against recombinant pro-memapsin 2. Crystallography of memapsin 2 bond to this inhibitor was used to determine the three dimensional structure of the protein, as well as the importance of the various residues in binding. This information can be used by those skilled in the art to design new inhibitors, using commercially available software programs and techniques familiar to those in organic chemistry and enzymology, to design new inhibitors to memapsin 2, useful in diagnostics and for the treatment and/or prevention of Alzheimer's disease.
Patent EP-1222001-B1 (EP)
Inventor: WALTER LEA
IPC: A62B1/04
Filed: 2000-10-19
Granted: 2004-12-08
Abstract: The invention relates to a security system for a rappelling device for securing persons, animals and objects that comprises a fixated guide part (2) and a movable buckle (3) which, in the rest position, fits into an L-shaped notch (4) of the fixated guide part (2) in such a manner so as rest in parallel against a base plate (1) that carries the fixated guide part (2).
Patent EP-1249019-B1 (EP)
Inventor: WINTER MARCO
IPC: G11B27/32
Filed: 2000-11-16
Granted: 2003-08-27
Abstract: DVD Stream Recording shall be used for realtime recording and playback of given packetized bitstreams. The data of the bitstream are organized into Stream Object Units, which in turn consists of stream packs (O_S_P) with a stream pack header (P_H) followed by a stream packet (S_PES_P), wherein a stream packet (S_PES_P) contains further header data (PES_H, S_ID, A_H) and an Application Packet Area (A_P_A), which is filled with a sequence of Application Packets each prefixed by an Application Time Stamp (ATS). In case of very low bitrate stream recording empty packets are recorded, which are marked as stuffing packets. This ensures that every Stream Object Unit - even in areas where stuffing is performed - contains at least one Application Time Stamp value.
Patent EP-1166993-B1 (EP)
Inventor: HERBST RICHARD
IPC: B29C45/17
Filed: 2001-05-19
Granted: 2004-08-04
Abstract: A horizontal guide (26) for a molding extraction arm (22) runs below (22b) it. Preferred features: The guide (26) is arranged below the mold components (12, 14). The second axis (24) is located at the guide. The arm pivots down about this axis, from its vertical position (22) into a horizontal position. Once horizontal, the plastic articles are transferred from the arm, onto a conveyor. The conveyor runs over the second axis. The equipment is employed in a clean room (40) with a laminar flow (41) directed vertically downward.
Patent EP-1179443-B1 (EP)
Inventor: LEMPERLE MARTIN
IPC: B60J7/22
Filed: 2001-07-14
Granted: 2006-05-31
Abstract: The wind deflector for convertible motor vehicles has a frame (12) in two sections (14a,14b) connected by hinges with a guiding edge on each of the sections for the flat material web stretched over the frame. The material web runs over each guiding edge which retains the portions of the material web extending in this frame section on a clamping face adjoining the frame at the side. Each of the clamping faces runs through the hinge axis (28) of the frame.
Patent EP-1213300-B1 (EP)
Inventor: AHRENS-FATH ISABELLE
IPC: C12Q1/6886
Filed: 2001-10-26
Granted: 2007-12-26
Abstract: Nucleic acid (I) that encodes an androgen receptor variant has a 1329 bp or 1171 bp sequence fully defined in the specification or its equivalents or a sequence that hybridizes to them under stringent conditions. Independent claims are also included for the following: (1) polypeptide (II) encoded by (I); (2) the peptides Asn-Cys-Glu-Arg-Ala-Ala-Ser-Val-His-Phe and Met-Ile-Leu-Trp-Leu-His-Ser; (3) antibody (Ab) specific for (II); (4) vector containing at least one copy of (I); (5) cells transfected with (I) or the vector of (4); and (6) test system for detecting effectors (III) of (II).
Patent EP-1349900-B1 (EP)
Inventor: YOUNG JAMES K
IPC: C09J7/38
Filed: 2001-12-18
Granted: 2007-02-14
Abstract: Methods, systems, and compositions that make it possible to form high resolution, pressure sensitive adhesive patterns or films on a wide range of substrates. The compositions generally incorporate a curable, fluid composition (i.e., pressure sensitive adhesive precursor). When cured, a pressure sensitive adhesive is formed. Ink jet printing and subsequent curing allows pressure sensitive adhesive features to be formed with high resolution and tremendous flexibility in the patterns by which adhesive features may be formed. Preferred embodiments of the invention incorporate rheology modifying agents that can be used to promote favorable dot gain and other printing characteristics, the ability to build print thickness, and mechanical properties of resultant cured adhesives.
Patent EP-1168791-B1 (EP)
Inventor: WILDMAN BURNETT JOHN GEOFFREY
IPC: H04M3/42
Filed: 2001-06-15
Granted: 2005-05-11
Abstract: A system and method for call-back handling are described. A call from a caller (1) to a client (7), is received (23) and the number at which the caller can be called back is determined (25). The call-back handler (9) then initiates a telephone call to the client through a public service telephone network standard line (27), either locally or on a public telephone network, and waits for the client to accept the call (29). Then, the caller is called (31) and the calls from call-back handler to client and to the caller are connected (33). <IMAGE>
Patent EP-1248623-B1 (EP)
Inventor: WOOD RALPH E
IPC: A61P17/02
Filed: 2001-01-11
Granted: 2004-12-29
Abstract: This invention relates to the use of cyclic guanosine 3', 5'-monophosphate phosphodiesterase type five (cGMP PDE5) inhibitors, including in particular the compound sildenafil, for the treatment of diabetic ulcers, particularly diabetic foot ulcers.
Patent EP-1256019-B1 (EP)
Inventor: ELLINGSRUD SVEIN
IPC: G01V3/12
Filed: 2001-02-01
Granted: 2004-06-09
Abstract: A system for detecting a subterranean reservoir or determining the nature of a subterranean reservoir (35) whose position and geometry is known from previous seismic surveys. An electromagnetic field (42,43) is applied by a transmitter (37) on the seabed (33) and detected by antenna (38) also on the seabed (33). A refracted wave component (43,43c) is sought in the wave field response, to determine the nature of any reservoir present. <IMAGE>
Patent EP-1250818-B1 (EP)
Inventor: LOEBIG NORBERT
IPC: H04Q3/00
Filed: 2001-01-24
Granted: 2007-10-10
Abstract: Commercially available platforms with performance characteristics are linked with network systems via standardized interfaces. Such a link, however, requires major interventions in the structure of said system. The inventive method reduces the necessary steps by means of a message-based concentration on the network bandwidth or a multiple thereof and a line-based concentration on the bandwidth of one of the peripherals during communication, thereby scheduling at least one interface of the allocated control device.
Patent EP-1256172-B1 (EP)
Inventor: BAIER THOMAS
IPC: H03H9/64
Filed: 2001-02-02
Granted: 2009-06-24
Abstract: The filter has reactance elements (RS1,RS2), is formed on a piezoelectric substrate, is configured as balanced/balanced, has symmetrical inputs and outputs with two connections each, is electrically symmetrical and has a four-pole reactance series element (VS) or two reactance elements with two poles. Each reactance element has interdigital converters with current rails connected to the input and output sides.
Patent EP-1266018-B1 (EP)
Inventor: PENTTILA MERJA E
IPC: C12N9/16
Filed: 2001-03-23
Granted: 2008-05-07
Abstract: Described herein are methods for increasing the amount of protein secreted by a cell. In one case, a cell is provided which contains a heterologous nucleic acid encoding a protein having unfolded protein response modulating activity and a heterologous nucleic acid encoding a protein of interest to be secreted. In one case, the protein having unfolded protein response modulating activity is selected from the proteins selected from the group consisting of HAC1, PTC2 and IRE1. The protein of interest can be any secreted protein such as a therapeutic or an industrial enzyme. For example the protein can be selected from the group consisting of lipase, cellulase, endo-glucosidase H, protease, carbohydrase, reductase, oxidase, isomerase, transferase, kinase, phosphatase, alpha-amylase, glucoamylase, lignocellulose hemicellulase, pectinase and ligninase.
Patent EP-1284860-B1 (EP)
Title: Impression par jet d'encre a systeme de circulation d'air
Inventor: MCELFRESH DAVID
IPC: B41J2/05
Filed: 2001-04-26
Granted: 2010-04-07
Abstract: Une imprimante à jet d'encre comprend une tête d'impression présentant une pluralité d'orifices d'encre formés dans celle-ci. Lors de l'impression, des gouttes d'encre sont éjectées par les orifices d'encre dans une zone d'impression entre la tête d'impression et un support d'impression, avec une trajectoire voulue des gouttes d'encre vers le support d'impression. Un système de circulation d'air dirige un flux d'air sur la zone d'impression sensiblement parallèlement à la trajectoire voulue des gouttes d'encre à mesure que ces dernières sont éjectées pendant l'impression, de manière à affecter des courants d'air agissant sur les gouttes d'encre pendant l'impression et empêcher des défauts d'impression provoqués par les courants d'air. Toutefois, le flux d'air n'interrompt pas la trajectoire voulue des gouttes d'encre pendant l'impression.
Patent EP-1259295-B1 (EP)
Inventor: CLAUSS TORSTEN
IPC: A62C31/02
Filed: 2001-02-27
Granted: 2010-03-31
Abstract: The invention relates to a method and a device for distributing liquid media, in particular extinguishing fluids for fighting fires, in the form of a mist or a stream of large droplets from a supply line which is maintained at a constant low-pressure, in rooms, for example in living spaces and recreation rooms, or similar. The aim of the invention is to provide a method and a device of the aforementioned type which can be used to produce a fine mist of small droplets and a jet spray of large droplets at separate moments, at approximately the same operating pressure of the extinguishing fluid, depending on the outbreak and the development of the fire, whilst at the same time minimising water consumption, reducing water damage caused during a fire and increasing cost-effectiveness, by creating a modular system which can be universally installed. To achieve this, the intensity of the vortex and the proportion of fine or large droplets in the spray cone is adjusted by regulating the quantity and speed of the flow of the sub-streams of extinguishing fluid, either separately or synchronously between a zero value and a maximum throughput value. In addition, the adjusting process is controlled by a signal generator which responds to the outbreak and dynamic development of the fire.
Patent EP-1274547-B1 (EP)
Inventor: HARTMANN MANFRED WOLFGANG
IPC: B26D1/40
Filed: 2001-04-06
Granted: 2007-09-19
Abstract: A printed, endless web is transversely cut by the cooperation of a cutting blade cylinder and a sheet gripping cylinder that also carries cutting blocks. If the web that is to be cut, is noted as having a defect, for example in the printing applied to it, the cutting blades can be withdrawn into the cutting blade cylinder and the deflective web can be diverted away from the folding apparatus.
Patent EP-1278593-B1 (EP)
Inventor: SCHAUERTE MANFRED
IPC: B01F5/06
Filed: 2001-04-20
Granted: 2005-03-23
Abstract: Static mixer element for homogenizing media and methods of mixing a drilling liquid are disclosed. The static mixer includes a housing and a deflection surface arranged within the housing at a selected angle with respect to the flow direction.
Patent EP-1303883-B1 (EP)
Inventor: FRIEDRICHS PETER
IPC: H01L29/78
Filed: 2001-07-13
Granted: 2010-11-03
Abstract: Semiconductor device has a semiconductor region (2) of one conductivity provided with a buried island region (3) of the opposite conductivity, having a contact region (5) of the first conductivity type at the surface (80 ) of the island region which is separated from the surface (20) of the semiconductor region via a lateral channel region (22), forming part of the current path to or from the contact region. The current (I) is controlled within this current path via at least one depletion zone (23,24) having a lateral edge extending as far as the contact region.
Patent EP-1299090-B1 (EP)
Inventor: CASTAN CATHERINE
IPC: A61K47/14
Filed: 2001-07-10
Granted: 2006-03-08
Abstract: The invention concerns a galenic system with prolonged/controlled release of the medicinal and/or nutritional active principle, for oral administration. The aim is to provide a system enabling to obtain with one single tolerable and acceptable dose of active principle, efficient therapeutic protection over 24 hours (increasing the bioabsorption time without affecting bioavailability). To achieve this, the invention provides a composition comprising two controlled release systems associated in series, namely: individualised coated particles (microcapsules) of active principle forming an internal phase, the coating comprising a film-forming polymer P1 (ethylcellulose), a nitrogenous polymer (polyvinylpyrrolidone), a softener (castor oil) and a lubricant (magnesium stearate), and an external phase of functional carriers: polyelectrolytic hydrophilic polymer: (alginate), neutral hydrophilic polymer (hydroxypropylmethylcellulose) and a gelling additive (calcium acetate), said composition spontaneously forming in the presence of water, a cohesive and stable composite macroscopic solid, wherein the external continuous phase is a gelled matrix including the active principle microcapsules. The invention is useful for delayed oral galenic formulation of metformin.
Patent EP-1295030-B1 (EP)
Inventor: GALTIER FREDERIC
IPC: F02P5/15
Filed: 2001-06-20
Granted: 2005-12-28
Abstract: Le procédé de protection en température pour tubulure d'échappement de moteur d'automobile, comporte des étapes de détermination d'un angle minimum d'avance à l'allumage parmi plusieurs valeurs possibles comprenant un angle de régime calé, en fonction d'une logique prédéterminée et de paramètres de fonctionnement du moteur.
Patent EP-1290383-B1 (EP)
Inventor: NOEHRIG ANDREAS
IPC: F24S23/71
Filed: 2001-05-18
Granted: 2008-01-16
Abstract: The lower edge (12) of the mirror is directly adjacent to its support plane. Seen in plan view, this edge is either straight or slightly-curved. The parabolic mirror (10) pivots up and down about a pivotal axis (36) located close to the support plane.
Patent EP-1316568-B1 (EP)
Inventor: FUJITA YUKIKO
IPC: C08L51/08
Filed: 2001-09-05
Granted: 2007-08-15
Abstract: Disclosed is an unsaturated polyester resin composition comprising an unsaturated polyester (A) and a polymerizable unsaturated monomer (B), wherein the "shrinkage stress upon cooling" of a cured article thereof is 17 MPa or less and the ratio of the "shrinkage stress upon cooling/elastic limit" is 1 or less. The cured article has excellent gloss retention and yellowing resistance.
Patent EP-1337210-B1 (EP)
Inventor: ECKMILLER ROLF
IPC: A61F9/007
Filed: 2001-12-03
Granted: 2005-11-30
Abstract: The invention relates to a removable anchoring element ( 3 ) for an implantable microcontact foil ( 2 ) used as a neuroimplant, especially for retina implants. The anchoring head rises above the surface of the implant, for fixing purposes, and the fixing device can be removed during the re-explantation or anchoring process by pulling the implant foil ( 2 ) beneath the anchoring head.
Patent EP-1369695-B1 (EP)
Inventor: WANDINGER KLAUS-PETER
IPC: G01N33/68
Filed: 2002-05-29
Granted: 2006-03-15
Abstract: This invention relates to a method for identifying an individual, in particular human, as a positive responder or a non-responder to a type-I Interferon (IFN) therapy, in particular IFN- beta therapy, used in the treatment of Multiple Sclerosis by determining TRAIL gene expression and/or TRAIL protein level. The invention further relates to the use of said method for monitoring IFN therapy in the treatment of Multiple Sclerosis and to a kit for carrying out said method.
Patent EP-1281832-B1 (EP)
Inventor: ROSSINI MAURO
IPC: E06B9/264
Filed: 2002-07-10
Granted: 2008-03-05
Abstract: An actuation assembly for double-glazing units with a frame with two glazed panes (13) that form a hermetic air space (14) accommodating shutters (15) movable to be gathered or rolled-up, which comprises rotary motion (24) speed varying (23) elements, with a first rotor (16), with a magnet ring (20) external to the unit (11) and a second rotor (17), with a magnet ring (39) arranged inside the unit (11) to surround coaxially thereto, the rotation shaft (18) on which the cords (22), from which the shutters hang, are wound. <IMAGE>
Patent EP-1288425-B1 (EP)
Inventor: MANN SIEGFRIED
IPC: E06B3/263
Filed: 2002-07-13
Granted: 2004-09-29
Abstract: The insulation (5) between the face profile (4) and wing frame (1.1, 2.1) comprises a profiled strip with a first groove (6) forming a form-fit joint with a connecting web (7) protruding from the face profile, and with a second groove (9) for receiving a connecting web (10) protruding from the fixed wing frame (2.1). A fastener (8) is used to secure the connecting webs to the profiled strip. The window comprises an opening wing (1) and a fixed wing (2), each wing frame preferably having a rectangular shape. A face profile attached to the outside of the fixed wing frame forms a stop for the opening wing, so that when the window is opened, the fixed wing either remains closed or is opened after the opening wing.